收费全文 | 732篇 |
免费 | 60篇 |
国内免费 | 2篇 |
耳鼻咽喉 | 5篇 |
儿科学 | 16篇 |
妇产科学 | 9篇 |
基础医学 | 150篇 |
口腔科学 | 31篇 |
临床医学 | 60篇 |
内科学 | 134篇 |
皮肤病学 | 22篇 |
神经病学 | 87篇 |
特种医学 | 18篇 |
外科学 | 75篇 |
综合类 | 2篇 |
预防医学 | 46篇 |
眼科学 | 13篇 |
药学 | 49篇 |
肿瘤学 | 77篇 |
2024年 | 3篇 |
2023年 | 8篇 |
2022年 | 14篇 |
2021年 | 36篇 |
2020年 | 20篇 |
2019年 | 26篇 |
2018年 | 31篇 |
2017年 | 26篇 |
2016年 | 22篇 |
2015年 | 34篇 |
2014年 | 28篇 |
2013年 | 57篇 |
2012年 | 45篇 |
2011年 | 74篇 |
2010年 | 30篇 |
2009年 | 31篇 |
2008年 | 40篇 |
2007年 | 47篇 |
2006年 | 40篇 |
2005年 | 38篇 |
2004年 | 32篇 |
2003年 | 41篇 |
2002年 | 28篇 |
2001年 | 2篇 |
2000年 | 3篇 |
1999年 | 2篇 |
1998年 | 7篇 |
1997年 | 5篇 |
1996年 | 4篇 |
1995年 | 3篇 |
1994年 | 1篇 |
1991年 | 2篇 |
1989年 | 1篇 |
1988年 | 1篇 |
1986年 | 2篇 |
1985年 | 1篇 |
1984年 | 1篇 |
1983年 | 3篇 |
1981年 | 1篇 |
1979年 | 1篇 |
1973年 | 1篇 |
1972年 | 1篇 |
1968年 | 1篇 |
The EQ-5D and the SF-6D are examples of commonly used generic preference-based instruments for assessing health-related quality of life (HRQoL). However, their suitability for mental disorders has been repeatedly questioned.
ObjectiveTo assess the responsiveness and convergent validity of the EQ-5D-3L and SF-6D in patients with depressive symptoms.
MethodsThe data analyzed were from cardiac patients with depressive symptoms and were collected as part of the SPIRR-CAD (Stepwise Psychotherapy Intervention for Reducing Risk in Coronary Artery Disease) trial. The EQ-5D-3L and SF-6D were compared with the HADS (Hospital Anxiety and Depression Scale) and PHQ-9 (Patient Health Questionnaire) as disease-specific instruments. Convergent validity was assessed using Spearman’s rank correlation. Effect sizes were calculated and ROC analysis was performed to determine responsiveness.
ResultsData from 566 patients were analysed. The SF-6D correlated considerably better with the disease-specific instruments (|rs|= 0.63–0.68) than the EQ-5D-3L (|rs|= 0.51–0.56). The internal responsiveness of the SF-6D was in the upper range of a small effect (ES: − 0.44 and − 0.47), while no effect could be determined for the EQ-5D-3L. Neither the SF-6D nor the EQ-5D-3L showed acceptable external responsiveness for classifying patients’ depressive symptoms as improved or not improved. The ability to detect patients whose condition has deteriorated was only acceptable for the EQ-5D-3L.
ConclusionOverall, both the convergent validity and responsiveness of the SF-6D are better than those of the EQ-5D-3L in patients with depressive symptoms. The SF-6D appears, therefore, more recommendable for use in studies to evaluate interventions for this population.
相似文献